Hillsdale Investment Management Inc. - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 38 filers reported holding PSYCHEMEDICS CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Hillsdale Investment Management Inc. ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q4 2019$11,0000.0%1,2000.0%0.00%0.0%
Q3 2019$11,000
-8.3%
1,2000.0%0.00%0.0%
Q2 2019$12,000
-29.4%
1,2000.0%0.00%
-50.0%
Q1 2019$17,0000.0%1,200
+9.1%
0.00%0.0%
Q4 2018$17,0000.0%1,100
+22.2%
0.00%0.0%
Q3 2018$17,000
+13.3%
900
+12.5%
0.00%0.0%
Q2 2018$15,000
-93.2%
800
-94.5%
0.00%
-96.5%
Q4 2014$220,000
+6.8%
14,5300.0%0.06%
-12.3%
Q3 2014$206,0000.0%14,5300.0%0.06%
+38.3%
Q2 2014$206,000
-17.3%
14,5300.0%0.05%
-32.9%
Q1 2014$249,00014,5300.07%
Other shareholders
PSYCHEMEDICS CORP shareholders Q1 2020
NameSharesValueWeighting ↓
22NW, LP 274,418$1,089,4390.78%
WEALTH EFFECTS LLC 40,701$161,5820.08%
Cannell Capital 74,794$296,9320.07%
SANTA MONICA PARTNERS LP 20,000$790.06%
RBF Capital, LLC 144,231$572,5970.04%
WEDBUSH SECURITIES INC 42,414$1680.01%
Ancora Advisors LLC 78,373$311,1410.01%
Your Advocates Ltd., LLP 1,400$5,5580.00%
CRAWFORD INVESTMENT COUNSEL INC 32,098$127,4280.00%
Renaissance Technologies 273,663$1,0860.00%
View complete list of PSYCHEMEDICS CORP shareholders